A meta-review from the University at Buffalo, published in NPJ Digital Medicine, assesses the value and limits of AI‑enhanced wearable devices for people with Type 2 diabetes and prediabetes. The authors screened about 5,000 peer‑reviewed studies and selected 60 that test how AI and wearables work together in diabetes management. Continuous glucose monitors (CGMs) provide frequent glucose readings that AI models can use to recognise patterns and predict changes before they occur.
The review highlights tangible benefits: AI-enhanced wearables can predict glucose changes up to one to two hours in advance, helping users keep steadier control and receive personalised guidance tied to daily routines, activity and sleep. These systems can also reduce clinical workload by filtering large streams of data and flagging items that require attention. For people with prediabetes, early use of wearables combined with AI could support lifestyle changes and possibly delay or prevent progression to diabetes. Raphael Fraser, the corresponding author, says AI can turn CGMs from a “rear-view mirror into a heads-up display.”
At the same time, the review identifies significant shortcomings. Research has been uneven and often focused on a few device types, data forms and AI models. Many models act as "black boxes," which undermines trust and clinical use. Limited sample sizes, narrow demographic representation, the absence of standard benchmark datasets and inconsistent data quality make it hard to compare studies. Practical barriers include limited integration into clinical workflows and the cost and accessibility of devices. Different AI approaches suit different tasks: models that learn patterns over time, such as long short‑term memory networks, often handle continuous glucose data well, while newer transformer models can combine multiple data types. Simpler models may be easier for clinicians to interpret, so the right AI must balance performance and explainability.
The authors conclude that larger studies, stronger validation and more transparent models are needed before AI-enabled wearables become routine in clinical care. The research received support from the American Diabetes Association, the National Institute of Diabetes and Digestive Kidney Disease, and the National Institute for Minority Health and Health Disparities.
Difficult words
- meta-review — a study that summarises many other studies
- continuous glucose monitor — a wearable device that measures blood sugar continuouslyContinuous glucose monitors, CGMs
- predict — to say or estimate a future event
- black box — a system whose internal process is not visibleblack boxes
- benchmark dataset — a standard set of data for comparing modelsbenchmark datasets
- transformer model — an AI model that combines different data typestransformer models
- integration — the process of including something into a system
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- What benefits and limits of AI-enhanced wearables seem most important for people with prediabetes or Type 2 diabetes?
- How should researchers balance performance and explainability when choosing AI models for clinical use?
- What practical steps could improve integration of these devices into clinical workflows and increase accessibility?
Related articles
People with AMD Judge Car Arrival Times Like Others
A virtual reality study compared adults with age-related macular degeneration (AMD) and adults with normal vision. Both groups judged vehicle arrival times similarly; vision and sound were used together, and a multimodal benefit did not appear.
Climate shocks, crop losses and health risks in Africa
Climate shocks in parts of Africa are hurting crops and helping pests and mosquitoes spread. Farmers face failed harvests and public health risks like malaria and cholera, while experts call for better infrastructure and funding.
Forest loss in tropics raises local heat and deaths
A study using satellite data found that tropical deforestation from 2001–2020 exposed 345 million people to local warming and likely caused about 28,000 heat-related deaths per year, mainly in Africa, Southeast Asia and Latin America.
Western Pacific priorities as WHO adapts after US withdrawal
WHO regional director Saia Maʻu Piukala outlines challenges and priorities for the Western Pacific as the organisation adapts after the US withdrawal. Key events include the World Health Summit in Berlin (12–14 October) and the Fiji Regional Committee (20–24 October 2025).